IRIS
MISSALE, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.823
EU - Europa 2.718
AS - Asia 1.064
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 2
Totale 6.612
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.795
IE - Irlanda 821
CN - Cina 816
SE - Svezia 647
IT - Italia 521
DE - Germania 204
FI - Finlandia 161
TR - Turchia 160
FR - Francia 152
UA - Ucraina 62
AT - Austria 38
SG - Singapore 34
BE - Belgio 26
CA - Canada 24
GB - Regno Unito 22
IN - India 21
NL - Olanda 19
RO - Romania 9
CZ - Repubblica Ceca 7
DK - Danimarca 6
ES - Italia 5
EU - Europa 5
HK - Hong Kong 5
CH - Svizzera 4
IR - Iran 4
MX - Messico 4
RU - Federazione Russa 4
JP - Giappone 3
LU - Lussemburgo 3
QA - Qatar 3
TH - Thailandia 3
TW - Taiwan 3
BD - Bangladesh 2
CO - Colombia 2
IL - Israele 2
KH - Cambogia 2
PK - Pakistan 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
EE - Estonia 1
HR - Croazia 1
KZ - Kazakistan 1
MK - Macedonia 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
Totale 6.612
Salva come PNG Salva come JPEG
Città #
Dublin 821
Chandler 620
Ashburn 238
Ann Arbor 201
Beijing 194
Dearborn 191
Princeton 147
Parma 143
Izmir 130
Nanjing 116
New York 108
Wilmington 99
Shanghai 95
Grafing 77
Jacksonville 69
Helsinki 62
Jinan 51
Milan 49
Shenyang 49
Des Moines 47
Bremen 43
Vienna 38
Seattle 33
Hebei 32
Kocaeli 30
Kunming 30
Tianjin 27
Nanchang 26
Hefei 24
Redmond 23
Ardea 22
Boardman 22
Rome 22
Los Angeles 21
Jiaxing 20
Brussels 18
Norwalk 18
San Mateo 18
Bologna 17
Guangzhou 17
Changsha 15
Fairfield 15
Fremont 15
Woodbridge 15
Falls Church 13
Toronto 12
Düsseldorf 11
Hangzhou 11
Montespertoli 11
Zhengzhou 11
Singapore 10
Limena 9
Reggio Emilia 9
Chicago 8
Mestre 8
Pune 8
Rockville 8
Modena 7
Terni 7
Borås 6
Brooklyn 6
Houston 6
Taastrup 6
Taiyuan 6
Washington 6
West Jordan 6
Binasco 5
Chengdu 5
Council Bluffs 5
Focsani 5
Haikou 5
Montreal 5
Ningbo 5
Central 4
Fuzhou 4
Lausanne 4
London 4
Manchester 4
Piacenza 4
Redwood City 4
Rio Saliceto 4
Vittuone 4
Waanrode 4
Wayne 4
Augusta 3
Bangkok 3
Cento 3
Cortemaggiore 3
Doha 3
Huizen 3
Lanzhou 3
Leuven 3
Luxembourg 3
Naples 3
Nepi 3
Neviano degli Arduini 3
Pisa 3
Rotondi 3
Santa Margherita Ligure 3
Shaoxing 3
Totale 4.380
Salva come PNG Salva come JPEG
Nome #
Role of immunoglobulin G fragment C receptor polymorphism-mediatedantibody-dependant1. cellular cytotoxicity in colorectal cancer treated withcetuximab therapy. Pharmacogenomics J. 152
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 123
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 108
Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma 93
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 92
Metabolic regulation of the HBV-specific T cell function 76
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 76
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma 72
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis 72
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 72
Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients 71
Resolution of late-onset heart and liver failures after reversion of jejuno-ileal bypass: a case report 70
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts 70
L-Asparaginase and Inhibitors of Glutamine Synthetase DiscloseGlutamine Addiction of Beta-Catenin-Mutated Human HepatocellularCarcinoma Cells 69
A simplified sars-cov-2 pseudovirus neutralization assay 69
Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. 67
Ex vivo characterization of tumor-derived melanoma antigenencoding gene-specific CD8 1 cells in patientswith hepatocellular carcinoma 67
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 65
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 65
Immune gene expression profile in hepatocellular carcinoma and surrounding tissue predicts time to tumor recurrence 64
Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma 64
Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation 62
Are Anti-TNF-α Agents Safe for Treating Psoriasis in Hepatitis C Virus Patients with Advanced Liver Disease? Case Reports and Review of the Literature 62
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells 61
T cell regulation in HBV-related chronic liver disease 60
Activation of Natural Killer Cells During Acute Infection With Hepatitis C Virus 59
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection 58
Circulating immune-profile as predictor of outcome in advanced NSCLC patients treated with Nivolumab 58
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines 58
Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab 58
Anti-Viral Intrahepatic T-Cell Responses can be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B 57
Neoplastic macrovascular invasion represents an independent risk factor for dismal survival in sorafenib treatment for hepatocellular carcinoma 56
Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer 56
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter 56
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection 55
Impact of Soluble CD26 on Treatment Outcome and Hepatitis C Virus-Specific T Cells in Chronic Hepatitis C Virus Genotype 1 Infection 55
Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID-19 patient 55
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV 55
The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus Infection 53
HBV immune-therapy: From molecular mechanisms to clinical applications 52
[68Ga]Nivolumab: a novel PET tracer to detect PD-1 expressing tumors 52
Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu-Positive Metastatic Breast Cancer. 52
Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. 50
Role of viral and host factors in HCV persistence: Which lesson for therapeutic and preventive strategies? 50
IMMUNE ESCAPE OF HEPATIC AND GASTROINTESTINAL CANCER:SECRETION OF SOLUBLE COMPLEMENT INHIBITORS 50
Radiofrequency Thermal Ablation for Hepatocellular Carcinoma Stimulates Autologous NK-Cell Response 49
Fine specificity of the human T cell response to hepatitis B virus core antigen 49
Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein 49
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study 49
Etanercept in the treatment of psoriasis and psoriathic arthritis with concomitant hepatitis C virus infection: clinical and virological study in three patients 49
Immune pathogenesis of hepatitis B 48
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 47
Oral lichen planus infiltrating T-cells:a Pathogenetic role for HCV-specific T cell responses? 47
Parenteral exposure to high HIV viremia leads to virus-specific T cell priming without evidence of infection 46
Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments 46
Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy 45
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 45
Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B 45
Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses 44
Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics 44
Antibody responses to hepatitis C virus hypervariable region 1: Evidence for cross-reactivity and immune-mediated sequence variation 43
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 42
Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection 42
Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment 42
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 42
AISF position paper on HCV in immunocompromised patients 42
TRANSCRIPTOME ANALYSIS OF EXHAUSTED VIRUS-SPECIFIC CD8 T CELLS IN CHRONIC HBV INFECTION IDENTIFIES PROFOUND METABOLIC AND FUNCTIONAL CELL DEFECTS 42
Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues 42
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma 42
Immunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma. 41
Head-injured subjects aged over 50 years: correlations between variables of trauma and neuropsychologial follow-up 41
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma. 41
Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection 41
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection 41
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection 39
Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/NEU-positive metastatic breast cancer 39
Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen 39
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C 38
Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses 38
The changing scenario of hepatocellular carcinoma in Italy: an update 38
Circulating immune-profile as predictor of outcome in NSCLC patients treated with nivolumab 38
High ASCT2 activity as a marker of extracellular glutamine dependence in ammoniagenic multiple myeloma cell lines 37
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group 37
Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development 37
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response 37
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection 36
Unraveling the multifaceted nature of cd8 t cell exhaustion provides the molecular basis for therapeutic t cell reconstitution in chronic hepatitis b and c 36
PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion 35
Metabolic disorders across hepatocellular carcinoma in Italy 35
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 35
The evolutionary scenario of hepatocellular carcinoma in Italy: an update 35
Comparative pathogenesis of HBV and HCV 34
Infection of circulating and liver infiltrating T cells by hepatitis C virus of different subtypes 34
Response prediction in chronic hepatitis c by assessment of IP-10 and IL28B-related single nucleotide polymorphisms 34
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma 34
Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation 33
Heterologous T cell immunity in severe hepatitis C virus infection 33
Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial 33
T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections 33
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro 33
Totale 5.233
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.048
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019184 0 0 0 0 0 0 0 0 0 0 157 27
2019/20201.089 195 100 27 22 56 198 116 53 109 139 55 19
2020/2021627 19 28 20 9 51 53 72 72 144 70 54 35
2021/2022727 19 21 26 53 47 91 38 54 36 21 44 277
2022/20232.802 318 250 185 172 168 298 53 157 988 25 116 72
2023/2024992 72 122 42 57 113 292 85 88 46 74 1 0
Totale 6.879